ConductScience.org, home

Paper36928165

RNA therapeutics.

Hastings ML and 1 other. RNA, 2023. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. RNA therapeutics. Papers, record 36928165. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36928165

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RNA therapeutics.
PubMed
Journal
RNA
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.8
iCite
Revised in PubMed
2023-07-06
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hastings MLMichelle Lhttps://orcid.org/0000-0002-4253-9261
2Krainer ARAdrian R

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RNAMajor topic
Drug Delivery SystemsMajor topic
RNA, Small Interfering

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DC012596NIDCD NIH HHSUnited StatesR01DC012596PubMed and NIHNIH RePORTER
R37 GM042699NIGMS NIH HHSUnited StatesR01GM042699PubMed and NIHNIH RePORTER
F31 NS076237NINDS NIH HHSUnited StatesF31NS076237PubMed and NIHNIH RePORTER
P01 CA013106NCI NIH HHSUnited StatesP01CA013106PubMed and NIHNIH RePORTER
R01 GM042699NIGMS NIH HHSUnited StatesR01GM042699PubMed and NIHNIH RePORTER
R01 NS069759NINDS NIH HHSUnited StatesR01NS069759PubMed and NIHNIH RePORTER
R37GM042699NIHNIH RePORTER

Download CSV of grants

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
41221298The role and targeting strategies of non-coding RNAs in immunotherapy resistance in oral squamous cell carcinoma.Front Cell Dev Biol2025https://conductscience.org/library/papers/41221298PubMed
40921731Developing Potent Therapeutics for Liver Cancer Chemoresistance via an RNA Nanotech and Series-Circuit-Christmas-Bulb Mechanism Targeting ABC Transporters.Mol Pharm2026https://conductscience.org/library/papers/40921731PubMed
40884791The bidirectional interplay between RNA processing and mechanotransduction.Cell Rep2025https://conductscience.org/library/papers/40884791PubMed
40515593RNA-targeting therapeutics: drugging the undruggable.Future Med Chem2025https://conductscience.org/library/papers/40515593PubMed
40197199The Regulatory Effects of Electroacupuncture on the Intestinal Flora of Mice with Ulcerative Colitis.Comb Chem High Throughput Screen2026https://conductscience.org/library/papers/40197199PubMed
40182424Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management.Front Cardiovasc Med2025https://conductscience.org/library/papers/40182424PubMed
40014258Toward an Extensible Regulatory Framework for N-of-1 to N-of-Few Personalized RNA Therapy Design.Ther Innov Regul Sci2025https://conductscience.org/library/papers/40014258PubMed
39967972Co-host ncRNA MIR503HG/miR-503-5p antagonistically interfere with the crosstalk between fibroblasts and microvascular endothelial cells by affecting the production of LMW FGF2 in pterygium.Int J Ophthalmol2025https://conductscience.org/library/papers/39967972PubMed
39699235Essential Considerations for Free Energy Calculations of RNA-Small Molecule Complexes: Lessons from the Theophylline-Binding RNA Aptamer.J Chem Inf Model2025https://conductscience.org/library/papers/39699235PubMed
39598489The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems.Pharmaceutics2024https://conductscience.org/library/papers/39598489PubMed
39011892Single-mode termination of phage transcriptions, disclosing bacterial adaptation for facilitated reinitiations.Nucleic Acids Res2024https://conductscience.org/library/papers/39011892PubMed
39005062Biogenesis and Function of circRNAs in Pulmonary Fibrosis.Curr Gene Ther2024https://conductscience.org/library/papers/39005062PubMed
38977892A (metaphorical) moment for RNA-based biotechnology? : Current metaphors for RNA limit development of and public communication about RNA-based technologies.EMBO Rep2024https://conductscience.org/library/papers/38977892PubMed
38919398DNA-based nanostructures for RNA delivery.Med Rev (2021)2024https://conductscience.org/library/papers/38919398PubMed
38351661Are non-protein coding RNAs junk or treasure?: An attempt to explain and reconcile opposing viewpoints of whether the human genome is mostly transcribed into non-functional or functional RNAs.Bioessays2024https://conductscience.org/library/papers/38351661PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36928165

GET https://conductscience.org/api/papers/v1/36928165/authors